WORKSHOP ON WHOLE SLIDE SCANNING IN TISSUE MEDICINE
Cordially Invites You
Industry news
News and announcements from our Industry partners
MajesTEC-9 clinical trial |Teclistamab (BCMAxCD3 bispecific antibody) in adults with relapsed or refractory multiple myeloma
To all members, please find the attached information about MajesTEC-9 trial. You may contact the principle investigators if your patient is eligible for the trial. Dr Lily Wonglilwongll@gmail.comPrincipal Investigator of Hospital Queen Elizabeth (Sabah)Dr Bee Ping Chongbpingchong@gmail.comPrincipal Investigator of University Malaya Medical Centre (Klang Valley)Dr Ng Soo Chinscng18@gmail.comPrincipal Investigator of Subang Jaya Medical Centre (Klang … Read more
Access to the Takeda Medical Education Portal
Dear MSH Members As part of our drive towards quality medical engagement, we would like to inform you that access to Takeda medical education portal is now available Please login to the MSH App, and in the Articles section you will see a PDF (image as below) Click on the link, and then Register to … Read more
COVID-19 and VTE and COVID-19 AF by Bayer
Greetings from Bayer Malaysia! COVID-19 is currently a hot topic all over the world and it affects each of us. As a partner with healthcare professionals, it is our responsibility to support in any way we can. Patients who are at risk of COVID-19 infection are often those who are at risk of suffering from … Read more
Medical reviewer required
See email from Mr Alattar: My company, TransPerfect Translations, is currently translating a document into languages for Malaysia. The project requires that a Chinese, Malay, and Tamil speaking hematologist, or physician with experience treating patients with hemophilia, review the translations to ensure that the material is appropriate for use with patients in Malaysia. We will … Read more
Ruxolitinib individual supply program
From Novartis A RUXOLITINIB INDIVIDUAL SUPPLY PROGRAM FOR PATIENTS WITH PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MYELOFIBROSIS (PPV-MF), OR POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS (PET-MF)
Early bcr-abl transcript levels predict future molecular response
More patients in the nilotinib arm vs the imatinib arm achieved BCR-ABL transcript levels ≤1% (56% vs 16%) and ≤10% (91% vs 67%) at 3 months. Early molecular response at 3 months correlated with future MMR and MR4.5 as well as an increased probability of freedom from progression and OS. Citation: A Hochhaus et al. … Read more
Haemoncrules updated!
Those of you who are using PDAs may be interested to know that I have at long last updated Haemoncrules. Version 2.3 now has 35 modules and the latest update has ET (WHO & PVSG) and PV (PVSG) diagnostic criteria. The software is free and you can view more details and download it at the … Read more
Seminar on Nucleic Acid Testing & Blood Banks
Synapse Sdn Bhd is organizing a lunch seminar on NAT in Blood Banks in collaboration with the Malaysian Society for Hematology on the 30th July and have organized the same talk in Penang on the 31st for the North.We would like to invite all members of MSH to the Seminar on the 30th of July … Read more
Velcade Launch Talk
Jannsen-Cilag in Collaboration with the Malaysian Society of Haematology will be holding a Talk by Professor Mario Boccadaro Date: Saturday 11 March 2006 Time: 2:30-5:30 pm (high tea included) Venue: KL Hilton